BiotechTV

•

Kênh • 5 chương trình

Khoa học đời sống

Khoa học đời sống

5 ngày trước
Khoa học đời sống

Khoa học đời sống

5 ngày trước
Khoa học đời sống

Khoa học đời sống

Hai tuần một lần
Khoa học đời sống

Khoa học đời sống

5 thg 3
Khoa học đời sống

Khoa học đời sống

2 thg 2

5 NGÀY TRƯỚC

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

He and Matt talk about portfolio construction, and the dynamics of taking on the right capital structure throughout different phases of a company's lifecycle. Neil shares early learnings from the commercial launch of Attruby, how being a commercial stage company can impact culture, and why he created the early-stage R&D focused sister company Gondola. Plus, discussing talent, intellectual property, and more.

5 ngày trước

•

42 phút
20 THG 4

Episode 38: Deerfield Management's Jason Fuller

He discusses his education and joining the Langer Lab at MIT, early experiences in venture, including at Third Rock and NEA, and gaining operational experience at Jounce before joining Deerfield. Plus, areas that interest him today and how he thinks about AI.

20 thg 4

•

1 giờ 6 phút
5 NGÀY TRƯỚC

Replimune's Chairman discusses FDA's polarizing decision to not approve the company's melanoma treatment after a new review. He says they have filed a FOIA request to learn more about FDA's process

Philip Astley-Starke describes the timeline of development of this oncolytic immunotherapy, his impression of FDA's review process and decisions around it, and the status of where the treatment stands today.

5 ngày trước

•

23 phút
17 THG 4

Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated

Plus, discussions on key trial readouts outside of obesity: eplontersen, Lp(a), oral IL-23, and milvexian.

17 thg 4

•

26 phút
20 THG 4

Physican and Biotech Investor Adam May reacts to this morning's 52 week Rezpeg data in alopecia from Nektar

He shares his thoughts on the data, the competitive profile of this IL-2 Treg therapy vs JAK inhibitors, and how the overall platform looks for other I&I conditions.

20 thg 4

•

14 phút
9 THG 4

Episode 5: John Maraganore has been a champion of innovation throughout his career. He discusses the road to success at Alnylam, today's environment, and keeping the U.S. on top

Reflecting on the decades-long journey at Alnylam, John Maraganore describes making it through lean times, and how far oligos and RNAi have come today. Matt asks him about championing true innovation, and what the word 'innovation' even means in today's environment. Plus, his thoughts on China, drug pricing and access, IP, AI ,and more.

9 thg 4

•

34 phút
6 NGÀY TRƯỚC

Invivyd develops monoclonal antibodies to prevent or treat infectious diseases. This approach could be useful in tamping down the measles outbreaks that have been occurring due to under-vaccination

CSO Robert Allen describes Invivyd's approach and why antibodies can be a good approach, especially as it relates to being resistant to viral evolution. He walks us through the science and some potential use cases.

6 ngày trước

•

23 phút
23 THG 3

Episode 37: SR One's Simeon George

Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.

23 thg 3

•

1 giờ 6 phút
19 THG 4

10x Genomics today is announcing Atera, its new in situ spatial transcriptomics platform

Co-Founder and CEO Serge Saxonov walks us through the platform, which can process up to 800 whole-transcriptome samples per year (1 cm² each) on a single instrument, scaling to thousands of samples per year for targeted assays, and has single-cell level sensitivity.

19 thg 4

•

14 phút
14 THG 4

Raymond James Biotech Innovation Symposium: Biotech analyst Tiago Fauth shares his read on the mood of investors and discusses companies he covers

He discusses Praxis, Insmed, Ionis, PTC Therapeutics, Rapport, and United Therapeutics.

14 thg 4

•

9 phút

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Trang Web

BiotechTV

Top Chương Trình

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

Episode 38: Deerfield Management's Jason Fuller

Replimune's Chairman discusses FDA's polarizing decision to not approve the company's melanoma treatment after a new review. He says they have filed a FOIA request to learn more about FDA's process

Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated

Physican and Biotech Investor Adam May reacts to this morning's 52 week Rezpeg data in alopecia from Nektar

Episode 5: John Maraganore has been a champion of innovation throughout his career. He discusses the road to success at Alnylam, today's environment, and keeping the U.S. on top

Invivyd develops monoclonal antibodies to prevent or treat infectious diseases. This approach could be useful in tamping down the measles outbreaks that have been occurring due to under-vaccination

Episode 37: SR One's Simeon George

10x Genomics today is announcing Atera, its new in situ spatial transcriptomics platform

Raymond James Biotech Innovation Symposium: Biotech analyst Tiago Fauth shares his read on the mood of investors and discusses companies he covers

Giới Thiệu

BiotechTV

Top Chương Trình

Top Tập Podcast

Giới Thiệu